News & Media
News & Media

News & Media

Follow us on our journey as we harness the power of radiopharmaceutical technology to take on cancer’s toughest tumors. This journey has brought us to a new name: We are now Mariana Oncology

Check back here for the latest on Mariana Oncology.

Mariana Oncology Announces $175 Million Series B Financing

Financing round led by Deep Track Capital and Forbion with participation from a syndicate of leading biotechnology investors Proceeds to support advancement of novel portfolio of precision, next-generation radiopharmaceuticals and transition into a clinical-stage company WATERTOWN, Mass., September 7, 2023 – Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to…

Mariana Oncology Expands Management Team, Appoints Linda Bain Chief Operating Officer and Chief Financial Officer
Mariana Oncology Recognized as a 2022 Prix Galien USA Nominee for Prix Galien Startup
Mariana Oncology Appoints Karen Smith, M.D., Ph.D., as Independent Board Director
Mariana Oncology Expands Radiopharmaceutical Expertise with Appointment of Bernard Lambert, Ph.D. as Chief Technology Officer
Mariana Oncology Appoints Kapil Dhingra, MBBS, to Board of Directors
Mariana Oncology Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals

Contact Us

Mariana Oncology
100 Forge, 6th Floor,
Watertown MA 02472

For Media:

For Investors: